Anticoagulant Rodenticides Market

Market Definition

Anticoagulant rodenticides refer to the chemicals used for controlling rodent populations by inhibiting blood clotting, which leads to lethal hemorrhage. This report explores the key drivers of market development, a detailed regional analysis, and a comprehensive overview of the competitive landscape shaping future market growth.

Anticoagulant Rodenticides Market Overview

The global anticoagulant rodenticides market size was valued at USD 722.5 million in 2024, which is estimated to be valued at USD 747.2 million in 2025 and reach USD 974.2 million by 2032, growing at a CAGR of 3.86% from 2025 to 2032. 

The growth of the market is driven by rising rodent populations as a result of rapid urbanization and poor waste management, which has led to increased infestations and a higher demand for effective rodent control solutions to protect public health.

Major companies operating in the anticoagulant rodenticides industry are BASF SE, Bayer AG, Syngenta, PelGar International Limited, Rentokil Initial plc, Bell Labs, Kalyani Industries Limited, Heranba Industries Ltd, Neogen Corporation, Liphatech, Inc., JT Eaton, A. SAJ AGRICARE PVT. LTD., Arbuda Agrochemicals Limited, and POMAIS Agriculture.

The market is shaped by the need to curb rodent infestations in both urban and rural settings by using effective pest control solutions. Industry dynamics are influenced by the need for safety, efficacy, and growing awareness of the environment and health impact. 

Regulatory scrutiny and evolving public expectations are leading manufacturers to introduce less toxic and more targeted products. Although traditional anticoagulants continue to dominate usage, the sector is gradually shifting toward sustainable and responsible practices in line with broader trends in modern pest management.

Key Highlights:

1. The anticoagulant rodenticides market size was valued at USD 722.5 million in 2024.
2. The market is projected to grow at a CAGR of 3.86% from 2025 to 2032.
3. North America held a market share of 36.22% in 2024, with a valuation of USD 261.7 million.
4. The first-generation anticoagulants (FGARs) segment garnered USD 429.4 million in revenue in 2024.
5. The pellets segment is expected to reach USD 494.3 million by 2032.
6. The household/residential segment is anticipated to witness the fastest CAGR of 5.40% during the forecast period.
7. Asia Pacific is anticipated to grow at a CAGR of 4.86% during the forecast period.

Market Driver

Growing Rodent Populations

The market is experiencing strong growth due to escalating rodent populations worldwide, insufficient waste disposal systems, and climate changes that create favorable breeding conditions. As rodents become more prevalent in urban and agricultural areas, the risk of property damage, food contamination, and disease transmission is on the rise.

• In January 2025, the National Library of Medicine reported 11 of 16 U.S. cities (69%) showed significant rat population increases. Tokyo, Louisville, and New Orleans experienced declines, while Dallas and Saint Louis had no significant trend. Cities experiencing higher temperature rises have reported the most significant increases in rat populations. This heightened threat drives both public and private sectors to invest in robust pest control solutions, which is expanding the market for anticoagulant rodenticides as a critical tool for managing rodent-related challenges.

Market Challenge

Environmental and Health Concerns

The widespread use of chemical rodenticides, particularly anticoagulants poses a significant challenge to the anticoagulant rodenticides market as environmental contamination and risks to non-target species, including pets, wildlife, and marine life, draw scrutiny and regulatory pressure. 

Persistent and bioaccumulative properties of these compounds can lead to secondary poisoning in predators and scavengers, threatening biodiversity. 

To resolve this, companies are adopting integrated pest management strategies, stricter product labeling, and less toxic and more targeted formulations, while emphasizingeducation on responsible use and the importance of proper waste disposal to minimize unintended exposure.

Market Trend

Technological Advancements and Digital Monitoring

The market is embracing technological advancements and digital monitoring as a defining trend, with smart pest monitoring systems becoming central to modern rodent control strategies. 

These systems utilize IoT-enabled sensors and AI-driven analytics to provide real-time detection, predictive insights, and targeted interventions, significantly enhancing pest management efficiency. 

By enabling early identification of infestations and precise action, digital monitoring reduces reliance on traditional chemicals, supports sustainable practices, and meets the growing demand for data-driven and proactive solutions across agriculture, residential, and commercial sectors.

• In October 2023, Syngenta unveiled SecureChoice, a smart remote rodent detection system, in the UK. This digital tool enables real-time monitoring, proactive alerts, and data-driven pest management, empowering professionals to deliver targeted rodent control with enhanced services for clients across various facilities.

Anticoagulant Rodenticides Market Report Snapshot

Segmentation	Details
By Type	First-Generation Anticoagulants (FGARs) Second-Generation Anticoagulants (SGARs)
By Form	Pellets, Blocks, Powders/Sprays
By Application	Agriculture, Warehouses, Household/Residential, Urban Centers, Others
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation:

• By Type [First-Generation Anticoagulants (FGARs), and Second-Generation Anticoagulants (SGARs)]: The First-Generation Anticoagulants (FGARs) segment earned USD 429.4 million in 2024, driven by continued use in regions where resistance and regulatory restrictions on newer products remain limited while supporting demand.
• By Form (Pellets, Blocks, and Powders/Sprays): The pellets segment held 48.43% of the market in 2024, owing to their ease of use, effective baiting, and compatibility across various rodent control environments and applications.
• By Application (Agriculture, Warehouses, Household/Residential, Urban Centers, and Others): The agriculture segment is projected to reach USD 369.8 billion by 2032, fueled by rising pest pressure and the need to protect crops and stored grains.

Anticoagulant Rodenticides Market Regional Analysis

Based on region, the global market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

The North America anticoagulant rodenticides market share stood at 36.22% in 2024, with a valuation of USD 261.7 million. The region remains dominant in the global market due to the high rodent population, rapid urbanization, and strict public health regulations. 

The region’s robust economy, advanced pest management infrastructure, and heightened awareness of rodent-borne diseases drive consistent demand for effective rodent control solutions. 

Stringent regulatory standards and the presence of leading manufacturers further reinforce North America’s leadership, as residential and commercial sectors prioritize advanced, safe, and sustainable rodenticide products to mitigate health risks and property damage.

Asia Pacific is poised for significant growth at a CAGR of 4.86% over the forecast period. The region is emerging as the fastest-growing market for anticoagulant rodenticides, driven by rapid urbanization, expanding agricultural activities, and heightened concerns about rodent-borne diseases in developing economies like India and China. 

This market is fueled by the need for improved hygiene standards and effective pest management solutions. Frequent rodent outbreaks, often triggered by unusual climatic conditions and abundant food supply in agricultural fields, further boost the demand for advanced rodenticides and integrated pest control strategies across both rural and urban settings.

Regulatory Frameworks

• In the U.S., the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) regulate pesticide registration, distribution, and use. It defines pesticides broadly as substances for pest control, plant regulation, or desiccation, with strict oversight and enforcement.
• In the EU, Regulation (EU) 528/2012 standardizes biocidal product rules, which require the approval of active substances and product authorization for market entry to protect health and environment, while promoting reduced animal testing through data sharing.

Competitive Landscape

Companies in the anticoagulant rodenticides market are actively expanding their product portfolios and investing in advanced formulations to address evolving regulatory and environmental concerns. They are mostly focusing on research and development to enhance product efficacy, safety, and sustainability. 

Strategic collaborations, mergers, and acquisitions are being pursued to strengthen market presence and distribution networks. Additionally, firms are prioritizing customer education and integrated pest management solutions to meet the rising demand for effective, responsible, and innovative rodent control across residential, commercial, and agricultural sectors.

• In May 2025, Syngenta and Neogen Corporation signed a licensing agreement, which granted Neogen exclusive rights to market and sell Talon-G and Talon Weatherblok XT rodenticides (containing brodifacoum) in the U.S. and Canada. This alliance positions Neogen to lead sales and distribution, while Syngenta focuses on advancing innovative pest control technologies.

List of Key Companies in Anticoagulant Rodenticides Market:

• BASF SE
• Bayer AG
• Syngenta
• PelGar International Limited
• Rentokil Initial plc
• Bell Labs
• Kalyani Industries Limited
• Heranba Industries Ltd
• Neogen Corporation
• Liphatech, Inc.
• JT Eaton
• SAJ AGRICARE PVT. LTD.
• Arbuda Agrochemicals Limited
• POMAIS Agriculture

Recent Developments (Product Launch)

• In October 2024, BASF SE relaunched the Neosorexa Plus Blocks rodenticide, featuring the potent active anticoagulant flocoumafen for rapid and effective control of resistant rodents. The new formulation combines palatability and durability, supporting pest technicians with a reliable solution for challenging infestations.